Hydroisoindoline tachykinin receptor antagonists

Details for Australian Patent Application No. 2006261930 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Devita, Robert J.; Kumar, Sanjeev; Tschirret-Guth, Richard A.; Mills, Sander G.; Jiang, Jinlong

Agent Spruson & Ferguson

Pub. Number AU-B-2006261930

PCT Pub. Number WO2007/002457

Priority 60/694,481 27.06.05 US

Filing date 23 June 2006

Wipo publication date 4 January 2007

Acceptance publication date 14 July 2011

International Classifications

C07D 209/46 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/4035 (2006.01)

Event Publications

10 January 2008 PCT application entered the National Phase

  PCT publication WO2007/002457 Priority application(s): WO2007/002457

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

14 July 2011 Application Accepted

  Published as AU-B-2006261930

10 November 2011 Standard Patent Sealed

11 October 2012 Alteration of Name

  The name of the patentee has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006261931-Non-nucleoside reverse transcriptase inhibitors

2006261920-Antibody formulations having optimized aggregation and fragmentation profiles